Literature DB >> 25662492

An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal "Myocardial Repair: PRP, Hydrogel and Supplements".

Thang Duc Vu1, Shripad N Pal1, Lian-Kah Ti2, Eliana C Martinez3, Abdul Jalil Rufaihah1, Lieng H Ling4, Chuen-Neng Lee5, Arthur Mark Richards4, Theo Kofidis6.   

Abstract

AIMS: Cell-based myocardial restoration has not penetrated broad clinical practice yet due to poor cell retention and survival rates. In this study, we attempt a translational, large-scale restorative but minimally invasive approach in the pig, aiming at both structurally stabilizing the left ventricular (LV) wall and enhancing function following ischemic injury. METHODS AND
RESULTS: A myocardial infarction (MI) was created by permanent ligation of left circumflex coronary artery through a small lateral thoracotomy. Thirty-six Yorkshire pigs were randomized to receive transthoracic intramyocardial injection into both infarct and border zone areas with different compounds: 1) Hyaluronic acid-based hydrogel; 2) autologous platelet-rich plasma (PRP); 3) ascorbic acid-enriched hydrogel (50 mg/L), combined with IV ibuprofen (25 mg/kg) and allopurinol (25 mg/kg) (cocktail group); 4) PRP and cocktail (full-compound); or 5) saline (control). The latter two groups received daily oral ibuprofen (25 mg/kg) for 7 days and allopurinol (25 mg/kg) for 30 days, postoperatively. Hemodynamic and echocardiographic studies were carried out at baseline, immediately after infarction and at end-point. Eight weeks after MI, the full-compound group had better LV fractional area change, ejection fraction and smaller LV dimensions than the control group. Also, dp/dtmax was significantly higher in the full-compound group when the heart rate increased from 100 bpm to 160bpm in stress tests. Blood vessel density was higher in the full-compound group, compared to the other treatment groups.
CONCLUSIONS: A combination of PRP, anti-oxidant and anti-inflammatory factors with intramyocardial injection of hydrogel has the potential to structurally and functionally improve the injured heart muscle while attenuating adverse cardiac remodeling after acute myocardial infarction.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidants; Heart failure; Hyaluronic acid-based hydrogels; Left ventricular restoration; Myocardial infarction; Platelet-rich plasma

Mesh:

Substances:

Year:  2015        PMID: 25662492     DOI: 10.1016/j.biomaterials.2014.12.013

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

Review 1.  Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence.

Authors:  Eleftherios Spartalis; Periklis Tomos; Demetrios Moris; Antonios Athanasiou; Charalampos Markakis; Michael D Spartalis; Theodore Troupis; Dimitrios Dimitroulis; Despina Perrea
Journal:  World J Cardiol       Date:  2015-10-26

2.  Controlled delivery of platelet-derived proteins enhances porcine wound healing.

Authors:  Daniel W Long; Noah R Johnson; Eric M Jeffries; Hidetaka Hara; Yadong Wang
Journal:  J Control Release       Date:  2017-03-14       Impact factor: 9.776

3.  Patient-Specific Bioinks for 3D Bioprinting of Tissue Engineering Scaffolds.

Authors:  Negar Faramarzi; Iman K Yazdi; Mahboubeh Nabavinia; Andrea Gemma; Adele Fanelli; Andrea Caizzone; Leon M Ptaszek; Indranil Sinha; Ali Khademhosseini; Jeremy N Ruskin; Ali Tamayol
Journal:  Adv Healthc Mater       Date:  2018-04-16       Impact factor: 9.933

Review 4.  Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.

Authors:  Yang Zhu; Yasumoto Matsumura; William R Wagner
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

Review 5.  Learning from Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal Large Tissue Defects.

Authors:  Ranieri Cancedda; Sveva Bollini; Fiorella Descalzi; Maddalena Mastrogiacomo; Roberta Tasso
Journal:  Front Bioeng Biotechnol       Date:  2017-04-28

Review 6.  Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction.

Authors:  Ming-Long Chang; Yu-Jui Chiu; Jian-Sing Li; Khoot-Peng Cheah; Hsiu-Hu Lin
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 7.  Targeted Myocardial Restoration with Injectable Hydrogels-In Search of The Holy Grail in Regenerating Damaged Heart Tissue.

Authors:  Faizus Sazzad; Michał Kuzemczak; Engracia Loh; Wellington Wu; Theo Kofidis
Journal:  Biomedicines       Date:  2021-05-24

Review 8.  Antifibrotic therapies to control cardiac fibrosis.

Authors:  Zhaobo Fan; Jianjun Guan
Journal:  Biomater Res       Date:  2016-05-25

9.  Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion.

Authors:  Elisa Garbayo; Juan José Gavira; Manuel Garcia de Yebenes; Beatriz Pelacho; Gloria Abizanda; Hugo Lana; María José Blanco-Prieto; Felipe Prosper
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

10.  Platelet-rich plasma: the role in neural repair.

Authors:  Margherita Giorgetti; Gabriele Siciliano
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.